World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
100
Citations
46652
World Ranking
8169
National Ranking
316

Harry J.M. Groen publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Harry J.M. Groen sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 632 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Harry J.M. Groen D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Harry J.M. Groen sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 100 D-Index — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Harry J.M. Groen is affiliated with the University Medical Center Groningen in the Netherlands. Their research primarily focuses on medicine, with a significant volume of work in pulmonary and respiratory medicine, oncology, cancer research, radiology, nuclear medicine and imaging, and molecular biology.

The scientist's work encompasses a broad range of topics related to lung cancer and cancer biology, including:

  • Lung Cancer Treatments and Mutations
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Research Studies
  • Cancer Genomics and Diagnostics
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Immunotherapy and Biomarkers
  • Colorectal Cancer Treatments and Studies

Several recent publications represent their contributions to the field. Notable papers include:

  • Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial, 2020, New England Journal of Medicine
  • Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer, 2020, New England Journal of Medicine
  • Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic Analysis, 2021, Journal of Thoracic Oncology
  • Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study, 2021, Journal of Thoracic Oncology
  • Immune microenvironment composition in non-small cell lung cancer and its association with survival, 2020, Clinical & Translational Immunology

Frequent collaborators in research include:

  • Ed Schuuring
  • T. Jeroen N. Hiltermann
  • Rozemarijn Vliegenthart
  • Anthonie J. van der Wekken
  • Marjolein A. Heuvelmans

The main publication venues for their research are:

  • Lung Cancer
  • Journal of Thoracic Oncology
  • Cancers
  • Annals of Oncology
  • Journal of Clinical Oncology

This researcher has contributed extensively to literature relating to lung cancer and related oncological fields. Their work spans clinical trials, treatment developments, diagnostic improvements, and molecular insights into cancer biology. The combination of topics, coauthors, and publication venues indicates a consistent focus on advancing understanding and treatment options in pulmonary oncology through interdisciplinary methods.

Best Publications

  • Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

    Harry J. de Koning;Carlijn M. van der Aalst;Pim A. de Jong;Ernst T. Scholten

  • Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

    Martin Peifer;Lynnette Fernández-Cuesta;Martin L. Sos;Julie George

  • Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

    Joe Y Chang;Suresh Senan;Marinus A. Paul;Reza John Mehran

  • Multiple common variants for celiac disease influencing immune gene expression

    Patrick C. A. Dubois;Gosia Trynka;Lude Franke;Lude Franke;Karen A. Hunt

  • Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial

    David Planchard;Egbert F Smit;Harry J M Groen;Julien Mazieres

  • Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer

    Jonathan Weiss;Martin L. Sos;Danila Seidel;Martin Peifer

  • Management of lung nodules detected by volume CT scanning

    Rob J van Klaveren;Matthijs Oudkerk;Mathias Prokop;Ernst T Scholten

  • An open-label phase 2 trial of dabrafenib plus trametinib in patients with previously treated BRAF V600E–mutant metastatic non-small cell lung cancer

    David Planchard;Benjamin Besse;Harry J M Groen;Pierre-Jean Souquet

  • A genomics-based classification of human lung tumors

    Danila Seidel;Thomas Zander;Lukas C. Heukamp;Martin Peifer

  • Complication rates of CT-guided transthoracic lung biopsy: meta-analysis

    W. J. Heerink;G. H. de Bock;G. J. de Jonge;H. J. M. Groen

  • Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial

    Dong-Wan Kim;Dong-Wan Kim;Marcello Tiseo;Myung-Ju Ahn;Karen L Reckamp

  • Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer

    Peter S. Hammerman;Martin L. Sos;Alex H. Ramos;Chunxiao Xu

  • 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

    Frederike Bensch;Elly L. van der Veen;Marjolijn N. Lub-de Hooge;Annelies Jorritsma-Smit

  • Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening

    Nanda Horeweg;Joost van Rosmalen;Marjolein A Heuvelmans;Carlijn M van der Aalst

  • Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer

    H.L. van Westreenen;M. Westerterp;P.M.M. Bossuyt;J. Pruim

  • Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial

    David Planchard;Tae Min Kim;Julien Mazieres;Elisabeth Quoix

  • Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA.

    Rudolf S. N. Fehrmann;Ritsert C. Jansen;Jan H. Veldink;Harm-Jan Westra

  • Nodule management protocol of the NELSON randomised lung cancer screening trial

    Dong Ming Xu;Hester Gietema;Harry de Koning;René Vernhout

  • Dual Inhibition of EGFR with Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer with and without T790M Mutations

    Yelena Y. Janjigian;Yelena Y. Janjigian;Egbert F. Smit;Harry J. M. Groen;Leora Horn

  • Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review.

    David Gilligan;Marianne Nicolson;Ian Smith;Harry Groen

Frequent Co-Authors

Egbert F. Smit
Egbert F. Smit VU University Medical Center
Wim Timens
Wim Timens University Medical Center Groningen
Matthijs Oudkerk
Matthijs Oudkerk University of Groningen
Ed Schuuring
Ed Schuuring University Medical Center Groningen
Anne-Marie C. Dingemans
Anne-Marie C. Dingemans Erasmus University Rotterdam
Harry J. de Koning
Harry J. de Koning Erasmus University Rotterdam
Leon W.M.M. Terstappen
Leon W.M.M. Terstappen University of Twente
Anke van den Berg
Anke van den Berg University Medical Center Groningen
Dirkje S. Postma
Dirkje S. Postma University Medical Center Groningen
Klaas Kok
Klaas Kok University of Groningen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in healthcare can look very different for each individual. For those looking to advance as nursing professionals while balancing work and life, cheapest online dnp programs offer a flexible and affordable route to the highest level of nursing practice. These programs are tailored for working nurses aiming for leadership and specialized roles.

If you want a faster entry into the medical field, consider fast track medical lpn pathways. These online programs allow students to gain licensure as Licensed Practical Nurses more quickly, helping them join the healthcare workforce sooner and with less financial strain.

For those interested in expanding their expertise in mental health, online pmhnp programs prepare nurses for in-demand psychiatric-mental health roles. Such specializations are crucial as mental health services become a larger focus in healthcare.

Not all healthcare professionals work in clinical settings. Individuals interested in leadership or the business side of medicine can explore healthcare administration degrees online, which open doors to management careers in hospitals, clinics, and insurance organizations.

Best Scientists Citing Harry J.M. Groen

Trending Scientists

Recently Published Articles